Skip to content

   Pharma Publications

Neuropsychopharmacology
  • The crosstalk between CREB and PER2 mediates the transition between mania- and depression-like behavior
    Published on 2025-02-26
    9 months ago
  • Connectome-based predictive modeling of early and chronic psychosis symptoms
    Published on 2025-02-26
    9 months ago
  • The prelimbic prefrontal cortex mediates the development of lasting social avoidance as a consequence of social threat conditioning
    Published on 2025-02-26
    9 months ago
  • A projection from the medial prefrontal cortex to the lateral septum modulates coping behavior on the shock-probe test
    Published on 2025-02-26
    9 months ago
  • Pharmacological reduction of reverse-translated hippocampal hyperactivity in mouse: relevance for psychosis
    Published on 2025-02-26
    9 months ago
  • Longitudinal associations between white matter integrity, early life adversities, and treatment response following cognitive-behavioral therapy in depression
    Published on 2025-02-25
    9 months ago
  • Protein interacting with C-kinase 1 (PICK1) regulates synaptic function and reversal learning in a mouse model for schizophrenia
    Published on 2025-02-21
    10 months ago
« Previous 1 … 29 30 31 32 33 … 143 Next »
Journal of Psychopharmacology
  • Insomnia and the effect of zolpidem-extended-release on the sleep items of the Hamilton Rating Scale for Depression in outpatients with depression, insomnia, and suicidal ideation: Relationship to patient age
    Published on 2024-08-09
    1 year ago
  • Impact of childhood adversity on acute subjective effects of stimulant and opioid drugs: Evidence from placebo-controlled studies in healthy volunteers
    Published on 2024-08-09
    1 year ago
  • Re-visiting the association between antidepressant use and the risk of lung cancer
    Published on 2024-08-09
    1 year ago
  • Combining bioinformatics, network pharmacology and artificial intelligence to predict the target genes of S-ketamine for treating major depressive disorder
    Published on 2024-08-09
    1 year ago
  • Evidence-based guidelines for the interpretation of the 9-item Concise Health Risk Tracking – Self-Report (CHRT-SR9) measure of suicidal risk
    Published on 2024-08-09
    1 year ago
  • Compassionate use of esketamine intranasal in patients with severe major depressive disorder resistant to the treatment
    Published on 2024-08-08
    1 year ago
  • Chronic Cannabis users exhibit altered oscillatory dynamics and functional connectivity serving visuospatial processing
    Published on 2024-08-01
    1 year ago
« Previous 1 … 29 30 31 32 33 … 134 Next »
European Neuropsychopharmacology
  • Points to consider when initiating clinical investigations in autistic paediatric populations–A White Paper
    Published on 2024-06-25
    1 year ago
  • Ketamine treatment for anhedonia in unipolar and bipolar depression: a systematic review
    Published on 2024-06-25
    1 year ago
  • Methodological issues around the comorbidity of obsessive-compulsive disorder and bipolar disorder
    Published on 2024-06-24
    1 year ago
  • Prader Willi syndrome, its psychiatric implications and their possible biological basis
    Published on 2024-06-24
    1 year ago
  • Letter to editor about the article “Clinical features in co-occuring obsessive-compulsive disorder and bipolar disorder: A systematic review and meta-analysis” (De Prisco M et al.,2023)
    Published on 2024-06-24
    1 year ago
  • Psychological symptoms after awake deep brain stimulation surgery in parkinson’s disease, essential tremor, and dystonia
    Published on 2024-06-23
    1 year ago
  • GLP-1 receptor agonists: A revolution in the treatment of Parkinson’s disease?
    Published on 2024-06-23
    1 year ago
« Previous 1 … 29 30 31 32 33 … 153 Next »

   Pharma Pub